From Pulse 2.0 · Amit Chowdhry · · 1m
TL;DR: Galvanize Therapeutics Raises $130 Million Series D
Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform.
Galvanize Therapeutics raised $130 million in Series D funding to commercialize its Aliya pulsed electric field platform and develop new applications in oncology and chronic disease. Galvanize Therapeutics secures $130M Series D to expand pulsed electric field ablation platform. Galvanize Therapeutics closed an oversubscribed $130 million Series D financing to expand commercial business, generate clinical evidence, and develop pulsed electric field technologies.
- Funding Round
- Investors
- Leadership
- Commercial Progress
Read the story version — the same reporting as a swipeable deck of 4 cards.

